{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:22:55Z","timestamp":1772515375160,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/md.0000000000007540","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T19:26:47Z","timestamp":1502220407000},"page":"e7540","source":"Crossref","is-referenced-by-count":8,"title":["Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization"],"prefix":"10.1097","volume":"96","author":[{"given":"Shutian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210309","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"R2-11-20210309","first-page":"1155","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"10","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"R3-11-20210309","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-11-20210309","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/REP-09-0568","article-title":"The adverse effects of obesity on conception and implantation","volume":"140","author":"Brewer","year":"2010","journal-title":"Reproduction"},{"key":"R5-11-20210309","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2008), consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Tarlatzis","year":"2008","journal-title":"Hum Reprod"},{"key":"R6-11-20210309","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum Reprod Update"},{"key":"R7-11-20210309","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0015-0282(16)55795-1","article-title":"Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome","volume":"59","author":"Kettel","year":"1993","journal-title":"Fertil Steril"},{"key":"R8-11-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R9-11-20210309","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fertnstert.2008.07.1711","article-title":"What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil Steril"},{"key":"R10-11-20210309","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"R11-11-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/09513590.2012.736561","article-title":"Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis","volume":"29","author":"Xiao","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R12-11-20210309","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/09513590.2013.860121","article-title":"A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"30","author":"Tu","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R13-11-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"R14-11-20210309","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-11-20210309","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","article-title":"Polycystic ovarian syndrome","volume":"99","author":"Alcalay","year":"2015","journal-title":"Med Clin N Am"},{"key":"R16-11-20210309","first-page":"524","article-title":"The characteristics and antidiastole of PCOS hyperandrogenism","volume":"21","author":"Qiao","year":"2005","journal-title":"J Pract Obstet Gynecol"},{"key":"R17-11-20210309","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10815-013-0090-2","article-title":"Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial","volume":"30","author":"Me","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R18-11-20210309","first-page":"6001","article-title":"Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study","volume":"9","author":"Xi","year":"2015","journal-title":"Drug Design Develop Ther"},{"key":"R19-11-20210309","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/oxfordjournals.humrep.a137874","article-title":"Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone","volume":"8","author":"Dickey","year":"1993","journal-title":"Hum Reprod"},{"key":"R20-11-20210309","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"R21-11-20210309","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/oxfordjournals.humrep.a137491","article-title":"Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome","volume":"6","author":"Hamilton-Fairley","year":"1991","journal-title":"Hum Reprod"},{"key":"R22-11-20210309","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/humrep\/der401","article-title":"Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study","volume":"27","author":"Homburg","year":"2012","journal-title":"Hum Reprod"},{"key":"R23-11-20210309","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"R24-11-20210309","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-11-20210309","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1089\/jwh.2008.0812","article-title":"Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response","volume":"17","author":"Shokeir","year":"2008","journal-title":"J Womens Health"},{"key":"R26-11-20210309","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)48069-6","article-title":"Clomiphene citrate: mechanism(s) and site(s) of action: a hypothesis revisited","volume":"42","author":"Adashi","year":"1984","journal-title":"Fertil Steril"},{"key":"R27-11-20210309","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate: end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod"},{"key":"R28-11-20210309","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/jcem-61-2-265","article-title":"Evidence for a hypothalamic site of action of clomiphene citrate in women","volume":"61","author":"Kerin","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-11-20210309","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"R30-11-20210309","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1472-6483(10)60926-1","article-title":"Assisted reproduction in the treatment of polycystic ovarian syndrome","volume":"8","author":"Urman","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"R31-11-20210309","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1990.tb00491.x","article-title":"Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles","volume":"33","author":"Shoham","year":"1990","journal-title":"Clin Endocrinol"},{"key":"R32-11-20210309","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/oxfordjournals.humrep.a137513","article-title":"Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process","volume":"6","author":"Chappel","year":"1991","journal-title":"Hum Reprod"},{"key":"R33-11-20210309","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertil Steril"},{"key":"R34-11-20210309","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/edrv.21.5.0409","article-title":"Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function","volume":"21","author":"Themmen","year":"2013","journal-title":"Endocr Rev"},{"key":"R35-11-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7827-10-36","article-title":"Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome","volume":"10","author":"Liu","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"R36-11-20210309","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/j.fertnstert.2013.07.854","article-title":"LH regulated gene expression in the ovary of PCOS women, a role for PEG3 and TCF21","volume":"100","author":"Gielen","year":"2013","journal-title":"Fertil Steril"},{"key":"R37-11-20210309","first-page":"214","article-title":"Effects of high serum LH levels during mild ovarian stimulation protocol on IVF outcome of patients with polycystic ovary syndrome: a matched case-control study","volume":"23","author":"Wen","year":"2014","journal-title":"J Reprod Med"},{"key":"R38-11-20210309","doi-asserted-by":"crossref","first-page":"96e1","DOI":"10.1016\/j.ajog.2015.08.009","article-title":"Minimal stimulation IVF vs conventional IVF: a randomized controlled trial","volume":"214","author":"Zhang","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R39-11-20210309","first-page":"137","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: a review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann Transl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:55:10Z","timestamp":1620960910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201708110-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":39,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007540","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}